Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients

Date

2015

Authors

Burke, M.
Morais, C.
Oliver, K.
Lambie, D.
Gobe, G.
Carroll, R.
Staatz, C.
Sinnya, S.
Soyer, H.
Winterford, C.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

American Journal of Clinical Pathology, 2015; 143(4):514-526

Statement of Responsibility

Michael T. Burke, Christudas Morais, Kimberley A. Oliver, Duncan L. J. Lambie, Glenda C. Gobe, Robert P. Carroll, Christine E. Staatz, Sudipta Sinnya, H. Peter Soyer, Clay Winterford, Nikolas K. Haass, Scott B. Campbell and Nicole M. Isbel

Conference Name

Abstract

Objectives: This study aims to investigate how immunosuppression influences the protein expression of antiapoptotic members of the Bcl-2 family—namely, Bcl-xL and Mcl-1—in nonmelanoma skin cancer (NMSC) and the peritumoral epidermis of renal transplant recipients. Methods: NMSC and peritumoral epidermis protein expression of Bcl-xL and Mcl-1 were assessed by immunohistochemistry in renal transplant recipients receiving tacrolimus or sirolimus and the general population not receiving immunosuppression. Results: NMSC from renal transplant recipients compared with patients not receiving immunosuppressant medications had a reduced Bcl-xL expression intensity (P = .042). Mcl-1 expression intensity in NMSC was decreased in tacrolimus-treated patients compared with sirolimus-treated patients and the nonimmunosuppressed population (P = .024). Bcl-xL expression intensity was increased in peritumoral epidermis compared with NMSC (P = .002). Conclusions: It was shown for the first time that Bcl-xL and Mcl-1 expression are widespread in the peritumoral epidermis and NMSC of renal transplant recipients. Importantly in NMSC, Bcl-xL expression was reduced with immunosuppression exposure, and Mcl-1 expression was reduced in tacrolimus-treated compared with sirolimustreated patients.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2015 by The American Society for Clinical Pathology

License

Grant ID

Call number

Persistent link to this record